His primary areas of study are Tumor necrosis factor alpha, Cell biology, Receptor, Immunology and Cancer research. The study incorporates disciplines such as Apoptosis, Immune system and B-cell activating factor in addition to Tumor necrosis factor alpha. Klaus Pfizenmaier has included themes like Ceramide and Biochemistry in his Cell biology study.
His Receptor study combines topics in areas such as Cytokine and Fusion protein. His Immunology study which covers Cytotoxic T cell that intersects with In vivo, Antigen, Interleukin 2 and Molecular biology. His research integrates issues of Cell culture and Cytotoxicity in his study of Cancer research.
His primary scientific interests are in Tumor necrosis factor alpha, Cell biology, Molecular biology, Cancer research and Immunology. His studies deal with areas such as Cytokine, Receptor, Biochemistry, Fusion protein and Programmed cell death as well as Tumor necrosis factor alpha. His work deals with themes such as Inflammation and Endocrinology, which intersect with Receptor.
His Molecular biology study deals with Cell culture intersecting with Gene expression. His studies in Cancer research integrate themes in fields like Cancer cell, Cancer, Apoptosis, Prodrug and Matrix metalloproteinase. His Immunology research includes themes of Cytotoxic T cell and In vivo.
His scientific interests lie mostly in Tumor necrosis factor alpha, Cancer research, Fusion protein, Antibody and Inflammation. His Tumor necrosis factor alpha study is concerned with Immunology in general. The Cancer research study combines topics in areas such as Stroma, Monoclonal, Cancer cell, Apoptosis and Anti pd 1.
The concepts of his Fusion protein study are interwoven with issues in In vitro, Ligand, Stereochemistry, Cell biology and Mutagenesis. His Antibody research integrates issues from Tumor microenvironment, Tumor necrosis factor receptor 1, Tnf receptor 1 and Antigen. His work carried out in the field of Inflammation brings together such families of science as Psoriasis, Pathology, Receptor, Dialysis and Pharmacology.
The scientist’s investigation covers issues in Tumor necrosis factor alpha, Immunology, Tumor necrosis factor receptor 2, Inflammation and Central nervous system. His Immunology study integrates concerns from other disciplines, such as In vivo and Cell biology. His work deals with themes such as Signal transduction, Homology and Transmembrane protein, which intersect with In vivo.
In his research, Fusion protein and Ligand is intimately related to In vitro, which falls under the overarching field of Cell biology. His research in Inflammation intersects with topics in Therapeutic effect, Neuropathic pain, Pharmacology and Agonist, Receptor. The Central nervous system study combines topics in areas such as Neurodegeneration, Programmed cell death and Neuroprotection.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumor necrosis factor signaling.
H Wajant;K Pfizenmaier;P Scheurich.
Cell Death & Differentiation (2003)
THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR
Matthias Grell;Eleni Douni;Harald Wajant;Matthias Löhden.
Cell (1995)
PKCu is a novel, atypical member of the protein kinase C family.
F.J. Johannes;J. Prestle;S. Eis;P. Oberhagemann.
Journal of Biological Chemistry (1994)
PKC zeta is a molecular switch in signal transduction of TNF‐alpha, bifunctionally regulated by ceramide and arachidonic acid.
Gertraud Müller;Mohamed Ayoub;Peter Storz;Jörg Rennecke.
The EMBO Journal (1995)
Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses
P Scheurich;B Thoma;U Ucer;K Pfizenmaier.
Journal of Immunology (1987)
Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway.
Lara Marchetti;Matthias Klein;Katalin Schlett;Katalin Schlett;Klaus Pfizenmaier.
Journal of Biological Chemistry (2004)
Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2.
Valerie Fontaine;Saddek Mohand-Said;Noelle Hanoteau;Céline Fuchs.
The Journal of Neuroscience (2002)
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes
M Rollinghoff;A Starzinski-Powitz;K Pfizenmaier;H Wagner.
Journal of Experimental Medicine (1977)
Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex
Angelika Hausser;Peter Storz;Susanne Märtens;Gisela Link.
Nature Cell Biology (2005)
Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.
K Pfizenmaier;P Scheurich;C Schlüter;M Krönke.
Journal of Immunology (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Stuttgart
University of Würzburg
University of Stuttgart
University of Erlangen-Nuremberg
Technical University of Munich
University of Cologne
Humboldt-Universität zu Berlin
University of Stuttgart
National and Kapodistrian University of Athens
St. Jude Children's Research Hospital
Washington University in St. Louis
University of Queensland
National Research Council (CNR)
University of Minnesota
Xi'an Jiaotong University
University of Cambridge
University of Minnesota
University of Maryland, Baltimore
Norwich Research Park
Norwegian Meteorological Institute
Swansea University
University of Hawaii at Manoa
Turku University Hospital
University at Buffalo, State University of New York
University of Iceland
Texas A&M University